Abstract
Redo heart transplant (HTx) patients may have higher levels of circulating antibodies due to the fact that they have been exposed to a foreign graft. In addition, these patients may have had additional blood transfusions which may have also contributed towards the development of circulating antibodies. It is not clear whether patients undergoing redo HTx are more sensitized compared to primary HTx recipients. Furthermore, it is not clear as to whether redo HTx patients have a higher tendency to develop more circulating antibodies following their second heart transplant surgery.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Paper Title
Journal
Date
